Clinical and Medico-economic Evaluation of Taken Care Associating Nutritional Support and Adapted Physical Activity for Malnourished, or at Risk of Undernutrition, Elderly People on Discharge From Hospital (NUTRIACTIF)

January 17, 2023 updated by: Gérond'if
In the hospital, one out of every two elderly people is malnourished. This condition of undernutrition generally worsens during hospitalization, where the effects of polypathology and psychological distress are added. Muscle loss due to inadequate dietary intake, hypermetabolism and immobilization results in the onset or worsening of mobility disorders and functional decline. After hospitalization, 30-50% of elderly people hospitalized in emergency in medical departments have lost autonomy in daily life. Nutritional management and adaptive physical activity (APA) could have synergistic action to improve the nutritional status and mobility of elderly patients. The short duration of the average stay the acute geriatric units (10-15 days) is not enough to renew, nor to re-educate patients. It seems important to continue these actions at home. The implementation of programs combining nutrition and adapted physical activity (APA) at the hospital exit has not been studied to date. We formulate the hypothesis that in elderly people who are malnourished or at risk of undernutrition, after hospitalization, a personalized home intervention combining nutritional advice and appropriate physical activity will limit their loss of autonomy.

Study Overview

Status

Terminated

Intervention / Treatment

Detailed Description

Interventional study with minimal risk and constraints, prospective, multicentre, randomised and controlled.

Population of interest:

  • Older people at least 70 years, malnourished or at risk of malnutrition, on discharge from hospital
  • Informal caregivers of patients included in study

Intervention at home of professionals:

Mixed intervention: nutritional support, carried out by the dieticians of " Saveurs et Vie ", in seven sessions over three months, combined with an adapted physical activity intervention (APA), carried out by " Siel Bleu " professionals, also at a frequency of seven sessions over three months, for a total of fourteen sessions.

Control arm will benefit from usual support (depending on practices of the department, prescription or not of oral nutritional supplements and physiotherapy at home, but without home intervention of adapted physical activity professionals or dieticians).

In addition to screening/inclusion visits (D0), three follow-up home visits are scheduled at D7, D45 and D90 for both study groups.

Inclusion visit (D0), performed in hospital in geriatric ward prior to hospital discharge. Verification of inclusion criteria, collection of consent by investigator, randomization, collection of inclusion data (socio-educational level, family status, assessment of autonomy (ADL, IADL, AGGIR) number of drugs, comorbidity (CIRS-G), cognitive status, biology performed during hospitalization (albumin, CRP, Vitamin D) and discharge prescription (NOC, nutritional advice, physiotherapy) are programmed to D7, D45 and D90 for both study arms.

Follow-up visits to D7, D45 and D90, carried out at home by a clinal research technician mandated by sponsor (Gérond'if). Assessment of autonomy (ADL, IADL, AGGIR scale), nutritional status (weight, height, self-evaluation of appetite, MNA), functional status (Grinding strength, 4-metre walking speed, SPPB), quality of life (EQ-5D), frequency and transit time of home help workers, whether family or professional. Acceptability of interventions for the home intervention arm.

2 patient/arms, a total of 372 patients divided as follows:

  • Interventional arm : Nutrition intervention with appropriate physical activity for 186 patients
  • Control arm: standard care for 186 other patients And up to 160 informal caregivers (family members) in both groups, or 80 caregivers per group (one caregiver per patient).

Inclusion period: 15 months. Follow-up period: 3 months/subject (patients and caregivers) Total length of study: 18 months

Study Type

Interventional

Enrollment (Actual)

47

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ile-de-France
      • Paris, Ile-de-France, France, 75018
        • Département de Gériatrie, Hôpital Bichat

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

70 years and older (Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Men or women aged at least 70
  • Hospitalized in acute geriatrics (UGA), with expected return to home directly after the UGA
  • Undernourished or at risk of undernutrition (MNA SF12)
  • Able to walk 4 metres without third party assistance
  • Able to understand and consent to the study
  • Good understanding of the French language
  • Living in Paris (department 75)
  • Patient affiliated with a social security scheme
  • Having read the information note and having agreed to participate in the study by signing the consent.

Exclusion Criteria:

  • Life expectancy less than 6 months
  • Chronic inflammatory pathology
  • Progressive cancer
  • Severe renal failure (creatinine clearance < 30ml/min/1.73 m2)
  • NYHA Stage III or IV Dyspnea
  • Chronic respiratory failure (oxygen therapy at home)
  • Liver failure (TP < 50%)
  • Severe depression
  • severe dementia, according to DSM V criteria
  • swallowing disorders with inhalation pneumonia
  • corticosteroids (> 10 mg prednisone/day long-term or equivalent)
  • Systolic blood pressure >200 mmHg
  • Unstabilized acute coronary syndrome
  • decompensated heart failure
  • Severe, uncontrolled ventricular rhythm disorders
  • High risk embolic intracardiac thrombus
  • Presence of medium to large pericardial effusion
  • Recent history of thrombophlebitis with or without pulmonary embolism
  • Obstacle to severe and/or symptomatic left ventricular ejection
  • Severe and symptomatic pulmonary hypertension
  • Inability to perform appropriate physical activities
  • Subject participating or having participated in a therapeutic trial within the last 3 months
  • Refusal to participate
  • Person under guardianship, guardianship or safeguard of justice

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control

The control group will benefit from the usual support (depending on the practices of the department, prescription or not of oral nutritional supplements and physiotherapy at home, but without home intervention of adapted physical activity professionals or dieticians).

In addition to screening/inclusion visits (D0), three follow-up home visits are scheduled at D7, D45 and D90 for both study groups.

Experimental: Nutrition intervention with appropriate physical activity

Intervention at home of professionals:

Patients in this arm will benefit from 14 home interventions

  • 7 home nutrition support (NS) sessions in 3 months or 1 session every 10 days (+/-4 days). These sessions will be conducted by a dietician from the company "Saveurs et Vie".
  • 7 home sessions of adaptive physical activity (APA) in 3 months, one session every 10 days (+/-4 days). These sessions will be conducted by professionals from association group "Siel Bleu".

In addition to screening/inclusion visits (D0), three follow-up home visits are scheduled at D7, D45 and D90 for both study groups.

Nutritional support in seven sessions spread over three months, combined with an adapted physical activity intervention (APA), also at a frequency of seven sessions spread over three months, or fourteen home sessions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of level of autonomy according Activities of Daily Living (ADL) score
Time Frame: 18 months
To assess the effect of taken care associating nutritional support and adapted physical activity (APA) on the independence of elderly people who are malnourished or at risk of malnutrition at the end of their stay in hospital.
18 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Assessment of of dependency according Gerontological autonomy group iso-resources (AGGIR ) score
Time Frame: 18 mois
18 mois
Assessment of undernutrition according Mini Nutritional Assessment (MNA)
Time Frame: 18 months
18 months
Assessment of gait, balance and muscle according Short Physical Performance Battery (SPPB) score
Time Frame: 18 months
18 months
Measuring quality of life according EuroQol- 5 Dimension (EQ-5D) scale
Time Frame: 18 months
18 months
Assessment of comorbidity according Cumulative Illness Rating Scale-Geriatric (CIRS-G) scale
Time Frame: 18 months
18 months
Assessment caregiver burden according Caregiver Subjective and Objective Burden (Zarit) scale
Time Frame: 18 months
18 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 28, 2019

Primary Completion (Actual)

March 12, 2021

Study Completion (Actual)

June 17, 2021

Study Registration Dates

First Submitted

May 9, 2019

First Submitted That Met QC Criteria

June 6, 2019

First Posted (Actual)

June 7, 2019

Study Record Updates

Last Update Posted (Actual)

January 19, 2023

Last Update Submitted That Met QC Criteria

January 17, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Under-nutrition or Risk of Undernutrition

Clinical Trials on Intervention

3
Subscribe